BioSpace News Archive

Lunit, a leading medical AI provider, announced that there will be 13 abstracts presented at this year’s RSNA, demonstrating its AI solutions for radiology through internally conducted studies as well as clinical studies from external radiologists.

Potential one-time gene therapy for the treatment of Duchenne, includes a novel, optimized microdystrophin transgene and REGENXBIO’s proprietary NAV ® AAV8 vector Commercial-scale cGMP material to be used in clinical development Company on track to submit IND by end of 2021.

NeoImmuneTech, Inc. today presented data from Phase 1 of an ongoing study at the Society for Neuro-Oncology (SNO) annual meeting.

Deciphera Receives European Commission Approval of QINLOCK ® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor.

Harvard MedTech today announced that senior sales and business development executive Mark Moore is joining the company as Senior Vice President, Market Partnerships.

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.

Nanocan Therapeutics Corporation today announced the appointment of Dr. Elder Granger, President and CEO of THE 5Ps, and Dr. Paul Wallner, Senior Vice President for Medical Affairs of Genesis Care USA , to its Advisory Board, effective November 22 , 2021.

The new factory is ready to start production to meet the increased demand for VINIA®.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting immunosuppressive myeloid checkpoints, today announced that management will participate in a fireside chat at the upcoming Evercore ISI 4th Annual HealthCONx Conference.